Back to Search
Start Over
G-protein-coupled receptor 41 in cardiomyocytes: Effect of butyrate on intracellular Ca 2+ and sarcomere shortening.
- Source :
-
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Dec 15; Vol. 38 (23), pp. e70207. - Publication Year :
- 2024
-
Abstract
- G-protein-coupled receptor 41 (GPR41) is a Gα <subscript>i</subscript> -coupled receptor activated by short-chain fatty acids (SCFAs). Here, we tested that GPR41 is also expressed in cardiomyocytes and exerts a direct negative inotropic effect when activated by SCFA butyrate. Primary cardiomyocytes were isolated from wild-type (WT) and GPR41 knockout (GPR41 <superscript>-/-</superscript> ) adult mice and intracellular Ca <superscript>2+</superscript> concentration and cell shortening were measured using the IonOptix system. RNA localization (RNAScope), quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence staining, and western blot were used to examine the expression of GPR41 in adult primary cardiomyocytes of WT and GPR41 <superscript>-/-</superscript> mice. The effect of butyrate on shortening and intracellular Ca <superscript>2+</superscript> transient via GPR41 was also tested in cardiomyocytes. We demonstrated for the first time the presence of GPR41s on cardiomyocytes. Butyrate dose-dependently decreased cell shortening and the amplitude of intracellular Ca <superscript>2+</superscript> transients in cardiomyocytes from WT but not GPR41 <superscript>-/-</superscript> mice. In WT cardiomyocytes, butyrate decreased caffeine-mediated amplitudes of intracellular Ca <superscript>2+</superscript> transients from the sarcoplasmic reticulum (SR). Moreover, the inhibitory effects of butyrate on cell shortening and intracellular Ca <superscript>2+</superscript> were pertussis toxin (PTX)-sensitive. Finally, butyrate decreased the activity of sarcoendoplasmic reticulum Ca <superscript>2+</superscript> -ATPase (SERCA) and cellular 3'-5'-cyclic adenosine monophosphate (cAMP) content. In conclusion, GPR41 is expressed on cardiomyocytes. Butyrate, a known GPR41 agonist, reduces cardiomyocyte shortening and intracellular Ca <superscript>2+</superscript> transient via decreasing Ca <superscript>2+</superscript> content in the SR by inhibiting SERCA activity in a PTX-dependent manner. These findings establish that GPR41 is directly activated by SCFAs to decrease contraction and intracellular Ca <superscript>2+</superscript> transient, highlighting the potential inhibitory role of GPR41 in cardiomyocytes.<br /> (© 2024 Federation of American Societies for Experimental Biology.)
- Subjects :
- Animals
Mice
Butyrates pharmacology
Mice, Inbred C57BL
Male
Cells, Cultured
Calcium Signaling drug effects
Myocardial Contraction drug effects
Myocytes, Cardiac metabolism
Myocytes, Cardiac drug effects
Receptors, G-Protein-Coupled metabolism
Receptors, G-Protein-Coupled genetics
Calcium metabolism
Mice, Knockout
Sarcomeres metabolism
Sarcomeres drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1530-6860
- Volume :
- 38
- Issue :
- 23
- Database :
- MEDLINE
- Journal :
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology
- Publication Type :
- Academic Journal
- Accession number :
- 39652079
- Full Text :
- https://doi.org/10.1096/fj.202402027R